Skip to main content
Caplight Logo









Mariposa Therapeutics

Mariposa Therapeutics

Private
CardiffHealthcare & Life Scienceshttps://mariposa.health/

Last Round

Seed

Mar 11, 2026

Total Funding Raised

$1M

Company Overview

Mariposa Therapeutics is a biotechnology company developing a first-in-class small molecule, MP5219, as a topical treatment for Epidermolysis Bullosa Simplex (EBS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Hardware Sales

AI Layer

Non-AI

Keywords

disease-modifying therapyEpidermolysis Bullosa SimplexEBSkeratin modulationsmall molecule therapyrare disease therapyfirst-in-class drugpreclinical biotechtopical drug deliveryorphan drug developmentdermatologygenetic skin disorderpharma licensingdrug discoveryIND-enabling studies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mariposa Therapeutics Comparables

Compare Mariposa Therapeutics with similar companies based on industry and business-model similarity.

Mariposa Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioMendics
83%
Paradigm Therapeutics, Inc.
77%
Aegle Therapeutics Corp
76%

Mariposa Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 11, 2026

Key People

Founding team and executive leadership

David Howat

Chief Executive Officer

Executive Team

Mariposa Therapeutics Investors

Notable investors and investment history

Mariposa Therapeutics investors
InvestorRounds
Development Bank of WalesSeed
DEBRA Research gGmbHSeed

Mariposa Therapeutics Filings

Explore SEC and related filing metadata, where available.

Mariposa Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mariposa Therapeutics's valuation, stock price, and market status.

Is Mariposa Therapeutics a public or private company?

Mariposa Therapeutics is a private company.

What is the current stock price of Mariposa Therapeutics?

Mariposa Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Mariposa Therapeutics worth (valuation)?

Valuation information for Mariposa Therapeutics is not publicly available.

Can I buy Mariposa Therapeutics stock?

Mariposa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mariposa Therapeutics's last funding round?

Funding round information for Mariposa Therapeutics is not publicly available.

Who are the main investors in Mariposa Therapeutics?

Investor information for Mariposa Therapeutics is not publicly disclosed.

Will Mariposa Therapeutics IPO soon?

No public IPO plans have been announced for Mariposa Therapeutics.

How can I track Mariposa Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mariposa Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCardiff
Employee Range4
Year Founded2019
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?